| Back |
|
| Achieve higher results at a great pace |
| Product Name: |
| Tablets |
| Rabeprazole 20 mg |
| Rapid power to erase acid peptic disorders |
| Ensures fastest inhibition of H+/K+ -ATPase (1) - The most rapid inhibition was achieved with Rabeprazole followed by Lansoprazole & Omeprazole, and then Pantoprazole. |
| Offers greater antisectretory effect over a 24 hrs. period than other PPI's (2) |
| Optimum healing rates nearly 100 % (3) |
| Convenient once daily dosage |
| Well Tolerated in short & long term studies of upto 2 years of duration (2) |
| In GERD - Provides faster relief of symptoms (upto 70-80%) on day 1 of therapy than other PPI's |
|
| Also available: RAZOTAS-DSR Capsules (Rabeprazole 20 mg, Domperidone 30 mg)
|
|
| Gastric Ulcers
|
| Duodenal Ulcers
|
| Erosive Oesophagitis
|
| GERD
|
| Nocturnal Gastric Pain
|
| Z.E. Syndrome
|
| NSAID's induced gastritis
|
|
Medical Jr.
| 1. Drugs 2003; 63(24)
|
| 2. Drugs 2001; 61(15)
|
| 3. Gatroenterology 2001 Apr; 120 Suppl. 1:581
|
|
| |
|
 |